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Abstract
The concern of a Cryptosporidium or Giardia waterborne outbreak due to
treated wastewater has had water treatment utilities using some of the highest
water cleansing technologies available. Cryptosporidiosis and Giardiasis are
severe diarrheal diseases which can lead to death, thus it is important that
appropriate steps are taken to assure these parasites are not present in the
effluent of treated wastewater. This study examined the results of 863 assays for
Giardia and Cryptosporidium on the effluent of wastewater treatment facilities
and found that county of collection, watershed of collection, and laboratory
analyzing the sample have the most significant impact on the detection of
Cryptosporidium oocysts and Giardia cysts in wastewater effluent and that there
were minimal but significant differences in method of treatment and method of
filtration. To date no other comprehensive analysis of this data has been done.
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Introduction
Cryptosporidium
Cryptosporidium is a protozoan coccidian parasite of the apicomplexa
phylum found in the respiratory and gastrointestinal tracts of many hosts.
Cryptosporidium species are ubiquitous in nature with worldwide distribution and
have mammalian, avian, piscine, and amphibian hosts (Fayer, 2010).
Cryptosporidium oocysts can be found in soil, surface water, recreational water,
drinking water, and fecal-contaminated food.
Although many hosts are capable of acquiring this organism, it is thought
that the main environmental reservoirs for this organism are cattle and rodents
(Chalmers et al 1997). Cryptosporidium has been a recognized cause of disease
for over a century but has widely garnered attention in the US since the 1970s as
an increasing cause of infectious disease. Cryptosporidium was recognized as a
disease causing parasite in 1907 by E.E. Tyzzer in mice and has been commonly
detected by veterinarians ever since (U.S. E.P.A., 2001). The first episode of
cryptosporidiosis in a human was recorded by Nime in 1976, in a 3-year old girl
in Tennessee. Since then, the incidence and prevalence of this organism have
been increasing. A large part of this is due to the discovery that much of the fatal
diarrheal diseases in HIV and AIDS patients is caused by Cryptosporidium (Kim
et al, 1998). Healthy individuals exhibit symptoms ranging from asymptomatic to
severe, but the infection is almost always fatal in immunocompromised patients
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(Pieniazek, et al, 1999). This has been a leading cause for a major portion of the
studies of Cryptosporidium species and pathogenesis as well studies for
increasing the efficacy of diagnostic testing.
Cryptosporidiosis is a mainly zoonotic disease transmitted to humans from
various mammals, birds, reptiles, and rodents through the fecal-oral route. It has
also been demonstrated to be an anthroponotic disease further adding to its
ability to be easily transmitted. The current number of species and the specific
described genotypes varies constantly as they are described and identified
through by polymerase chain reaction (PCR) and gene sequencing (Champliaud,
et al, 1998). Methods for serological testing for antibodies to Cryptosporidium sp.
have been effective in detecting different species of this organism from a variety
of hosts (Priest, et al, 2006). Over 40 genotypes and 15 species of
Cryptosporidium have been described (Ruecker, et al, 2007). Although there
have been several species of Cryptosporidium there are currently eight that have
been found to be infective to and pathogenic in humans: C. parvum, C. hominis,
C. meleagridis, C. felis, C. canis, C. muris, C. suis and C. corvine (Kosek, et al,
2001). Of these species C. parvum, C. hominis, and C. meleagridis, respectively,
are the organisms that cause the highest levels of disease in humans. An
increasing number of species are being proven to infect humans, including
strains thought as only host specific (Xiao, et al, 2001).
The species causing the highest rate of disease in humans is C. parvum
although C. hominis is considered to be the human specific species. Most
mammals are infected with host-specific species of Cryptosporidium. These are
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generally infections throughout a domesticated animal community. Some wild
mammals can become infected by another host-specific species through
practices such as coprophagia, a demonstrated common behavior in foxes. The
most likely explanation for this is that C. parvum is a widely infective species and
is hosted by a variety of domesticated animals. Cows are a known host of this
organism and transmission is thought to occur by general contact as well as
through the ingestion of unpasteurized milk. Once infected, this organism is
easily spread from human to human (Pieniazek, et al, 1999).
A topic of controversy has been the exact route through which humans are
infected with this organism. The main question is whether the specific organisms
are being shed by animals in water that eventually comes into contact with
drinking water or if transmission occurs by another route. There have been
several studies demonstrating the connection between Cryptosporidium
harboring wild mammals and the occurrence of Cryptosporidium oocysts in runoff
and storm water (Cizek et al, 2008) (LeChevallier, Norton, & Lee, 1991). Hence
these animals can be a source of Cryptosporidium in watersheds and source
water (U.S. E.P.A., 2001). Zhou, et al (2004) found that animals inhabiting areas
where possible watershed contamination is present, were shown to be infected
by species that cause no known illness in humans. To date few studies
determining the differing concentrations of Cryptosporidium species infectious to
humans in water sources have been completed. While non-pathogenic species
may infect watersheds, and thus can be detected by the current standard assay,
USEPA Method 1623, the ratio of non-pathogenic to pathogenic is not known
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(Ruecker, et al, 2007). Any detection of Cryptosporidium oocysts can be seen as
a public health threat.
After infection with Cryptosporidium some people may be completely
asymptomatic while still shedding high levels of oocysts. For most infected
people,the symptoms of watery diarrhea, stomach pain or cramps, dehydration,
nausea, vomiting, fever, and weight loss start seven to ten days after being
infected. These symptoms usually persist for one to two weeks, but can range
from a few days to several weeks. In otherwise healthy immunocompetent
persons the disease and infection is self-limiting (Pieniazek, et al, 1999). During
the complicated lifecycle there is the possibility of autoinfection and thus patients
may have symptoms that come and go for a period lasting up to a month.
When the immune system is compromised or the infected person has
another infection or disease, the Cryptosporidium infection may last longer and
have more severe symptoms (Pozio, et al, 1997). In many HIV positive and AIDS
patients cryptosporidiosis is a fatal disease causing unrelenting diarrhea
(Pieniazek, et al, 1999).
An infected host sheds the infectious thick-walled oocysts of
Cryptosporidium which then contaminates food and water sources. The
complicated lifecycle of Cryptosporidium begins with ingestion of the thick-walled
oocysts. The oocyst releases sporozoites which then invade the lumen and lungs
and undergo asexual reproduction. The sexual reproduction phase then takes
place with the female macrogamonts and male microgamonts resulting in
fertilization. The following zygote develops into thin-walled oocysts that autoinfect
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the host and thick-walled oocysts that exit the host through feces (Current &
Garcia, 1991).
Cryptosporidiosis diagnosis is done with various microscopy, staining, and
antibody detection procedures used to detect oocysts in feces. Multiple staining
techniques such as an acid-fast staining, giemsa staining, and auramine staining
can be used to detect oocysts. Tissue biopsies of the small intestine can be
stained with hematoxylin and eosin which shows oocysts attached to the
epithelial cells. Antigen/antibody detection techniques such as direct fluorescent
antibody (DFA), immunofluorescent assays enzyme-linked immunosorbent assay
(ELISA), and polymerase chain reactions (PCR) are extremely useful in
diagnosis (Jex, et al, 2008).
There is no proven preventative or curative treatment for cryptosporidiosis
(U.S. E.P.A. 2001), but nitazonaxide and parmomycin are showing promise in
treatment of cryptosporidiosis (Chakrabarti and Chakrabarti, 2009). While
mammalian infections caused from Cryptosporidium are generally limited to the
gastrointestinal tract, there have been respiratory tract infections caused by this
organism as well. Respiratory tract infections have been found in avian and
mammalian species (Akiyoshi et al, 2003). Cama in 2007 noted that HIV-positive
patients commonly acquire the respiratory version of this disease (Cama, et al,
2007). Studies, such as that of Mercado et al (2007) and Mor et al (2010),
indicate the potential for transmission of Cryptosporidium by respiratory
secretions. Those studies also demonstrate that healthy immunocompetent
people testing positive for gastrointestinal Cryptosporidium have also tested
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positive for Cryptosporidium in their sputum. In a study of 926 children in
Uganda by Mor et al. (2010), Cryptosporidium DNA was found in the sputum of
35% of the children who were positive for gastrointestinal Cryptosporidium. Of
those children, 94% of them were HIV-seronegative. In the control population of
children who were negative for gastrointestinal Cryptosporidium and tested for
respiratory Cryptosporidium 100% of them were negative for respiratory
Cryptosporidiosis. In this study, the sputum was analyzed by molecular methods
for the detection of Cryptosporidium DNA; microscopic assays for the detection
of Cryptosporidium oocysts or sporozoites were not performed. This means while
present in the respiratory tract Cryptosporidium may not be transmissible by
respiratory secretions. There has been no evidence found that respiratory
Cryptosporidium is caused by gastrointestinal cryptosporidiosis. The third most
common species of Cryptosporidium to infect humans, C. meleagridis, is the
most common organism found in many avian species. In several studies
respiratory transmission of this organism in avian species has been established.
This species of Cryptosporidium has been shown to infect humans as well as
avian species and infects non-human species primarily by respiratory secretions
(Akiyoshi, 2003). Since this leads to the possibility of a higher than known
respiratory transmission of Cryptosporidium, further examination of the possible
public health threats this poses is warranted.
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Giardia
Giardia duodenalis, also known as G. lamblia and G. intestinalis, is a
flagellated protozoan parasite in the Metamonada phylum. Giardia is ubiquitous
worldwide with a wide range of mammalian and avian hosts. There are an
estimated 2.5 million cases of Giardiasis annually. While the highest burden of
disease caused by Giardia is in developing countries, in developed countries
Giardia is the most prevalent intestinal parasite (Furness, 2000). Humans are a
main reservoir for Giardia although it is found in many small aquatic and semiaquatic mammals (Baker, 2007). Giardia can be found in surface water, lake and
pond water, water from shallow wells, and recreational water facilities such as
pools, beaches, and fountains. As with Cryptosporidium, Giardia is a zoonotic
disease (Feng & Xiao, 2011). Different infective species of Giardia have been
found in cats, dogs, cattle, deer, and beavers. Numerous cases of campers
acquiring the disease from water inhabited by beavers have given this disease
the nickname “beaver fever”.
Giardia was first noted by Antony van Leeuwenhoek in 1681 after an
examination of his own fecal matter. In 1859 Vilem Lambl described and
illustrated its morphology and was again described in 1895 by Alfred Giard. Over
two centuries since its first description passed before Giardia was associated
with diarrheal diseases in 1902 by Charles Stiles (Cox, 2002). In 1954 Rendtorff
officially linked the parasite with diarrheal disease.
Over 40 species of Giardia have been described but only six
morphologically distinct species are recognized: G. lamblia, G. muris, G. ardeae,
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G. psittaci, G agilis, and G. microti. The species G. lamblia is the main species
thought to infect humans. G. lamblia, G. microti, and G. muris are found in
mammals, G. ardeae and G. psittaci in birds, and G. agilis has been isolated
from amphibians. Many species of Giardia appear morphologically identical and
thus naming and identifying different species has been difficult (Adam, 2001).
A Giardia infection starts with the ingestion water or food that has been
contaminated with fecal matter containing cysts. Once a cyst is ingested
excystation occurs in the stomach or in the duodenum. The excysted
trophozoites undergo asexual reproduction through binary fission in the small
intestines. At this point some of the trophozoites continue to asexually reproduce
causing autoinfection. The rest of the trophozoites encyst while in the large
intestines and get passed through the remainder of the digestive tract in feces.
While trophozoites and cysts get passed out of the body in feces only the cyst
form is able to survive outside the host (Adam, 2001).
Unlike Cryptosporidium, Giardia only colonizes the lumen of an infected
host. The major of infections are asymptomatic but they can cause acute or
chronic diarrheal illnesses. The primary symptoms of infection are diarrhea,
malaise, foul smelling flatulence, steatorrhoea (pale, foul, greasy stools),
abdominal cramps, bloating, nausea, vomiting, and weight loss start one to three
weeks after exposure. Giardiasis is generally a self-limiting disease with
dehydration being the main health concern (Gardner & Hill, 2001).
Diagnosis of Giardiasis entails an ova and parasite examination of feces
that is routinely repeated for a total of three specimens. Cyst detection from feces

8

aids in diagnosis in over 80% of patients. While ELISA assays are available, they
are much more costly and should not take the place of stool examination. A
majority of Giardiasis cases can be treated with anti-parasitic nitroimidazole
medications (Gardner and Hill, 2001). Because of the dramatic fluid loss
Giardiasis induced diarrhea can cause a main component of treatment is fluid
and electrolyte management (Guerrant et al 2001). When the immune system is
compromised or the infected person has another infection or disease, the
infection may last longer and have more severe symptoms, but unlike
Cryptosporidium it is not usually fatal as effective treatment therapies are widely
available (Gardner & Hill, 2001).
.
Cryptosporidium and Giardia Water Safety Threat
The infectious oocysts and cysts of Cryptosporidium and Giardia,
respectively, are found in the feces of infected animals (Hunter & Thompson,
2005). Both Cryptosporidium and Giardia are organisms that pose a health threat
in developed, as well as developing, countries. The World Health Organization
placed these parasites on its list of neglected diseases due to the need for further
preventative and treatment method research (Chakrabarti and Chakrabarti,
2009).
The main public health threat currently posed by these organisms is a
waterborne outbreak. Cryptosporidium and Giardia concerns arise because: they
are easily spread through ingestion of contaminated drinking water, recreational
water, and food; easily spread by fecal-oral routes involving animals and soil; and
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Cryptosporidium is highly resistant to disinfection by chlorination at levels that are
not toxic to people (Kosek, et al, 2001). Due to these concerns both organisms
have been labeled as Category B Bioterrorism Agents. A Category B
Bioterrorism Agent is defined as an agent that is moderately easy to disseminate,
results in moderate morbidity and low mortality rates, and requires specific
enhancements of the CDC’s diagnostic capacity and enhanced disease
surveillance. Some examples of other Category B agents are brucella, epsilon
toxin (clostridium perfringens), salmonella, E. coli 0157:H7, Q fever, ricin toxin,
typhus fever, and other water safety threats (Rotz et al, 2002).
An example of the devastating effects of an outbreak (not due to
bioterrorism) is the 1993 waterborne outbreak of Cryptosporidium in Milwaukee,
Wisconsin. The outbreak occurred as a result of ineffective water filtration of a
municipal potable water supply. While the obvious health effects of this outbreak
were monitored it is one of the few Cryptosporidium outbreaks that had a
retrospective cost-of-illness analysis. An estimated 403,000 people become ill
and 104 died with the total cost of illness being approximately $96.2 million:
$31.7 million in direct medical costs and $64.6 million in productivity losses
(Corso, et al, 2003). In 1998 the main water supply in Sydney, Australia was
contaminated with Cryptosporidium and Giardia, affecting over three million
residents (Stein, 2000). In Florida there have been over 1,000 cases of
Giardiasis reported annually for more than a decade. In 2006 a neighborhood
water fountain became contaminated resulting in an outbreak with 38 cases of
Giardiasis, 9 cases of cryptosporidiosis, and 2 cases of co-infection (Eisenstein,
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Bodager, & Ginzl, 2008). According to the US EPA almost all of the
Cryptosporidium outbreaks in the US after 1985 occurred as a result of a fault in
treatment and/or filtration of water (US EPA, 2001). It is apparent that
cryptosporidiosis and Giardiasis are diseases of major concern due to their
health and economic impacts.
Enhanced water purification protocols were put into place in an effort to
stem the spread and occurrence of Giardia and to prevent Cryptosporidium from
getting into any potable water source. As both of these diseases are generally
spread in a fecal-oral route, the highest degree of action was taken in the
treatment of source water and wastewater that are open to the environment.
Current requirements apply to public water systems that use ground or surface
water that is under the direct influence of surface water, the types of water that
are most susceptible to protozoan contamination.
In 1974 the U. S. Congress enacted the Safe Drinking Water Act as a
public health measure to assure the safety of the nation’s drinking water supply.
The regulations enacted examine chemical, microbiological, physical, and
radiological contamination in water. This act was later amended and in 1989,
Giardia was added as a contaminant for regulation. In 1998 the Interim
Enhanced Surface Water Act was created to further control Cryptosporidium. The
long Term 1 Enhanced Surface Water Treatment Rule was enacted in 2002 and
lead to the current Long Term 2 (LT2) Enhanced Surface Water Treatment Rule
developed in 2006. The goal of these rules is to control microbial pathogens in
water while minimizing the public health risks of disinfectants, disinfection

11

byproducts, and chemical contaminants. Under the LT2 rule, source water
treatment facilities must submit monthly samples for two years or semimonthly
samples for one year for examination of Cryptosporidium and Giardia if they fail
initial E. coli coliform or state-approved alternate indicator monitoring. If the levels
of E. coli detected exceed the acceptable limits source water monitoring of
Cryptosporidium is required.
The Safe Drinking Water Act Amendments of 1996 require the US EPA to
evaluate public health risks posed by drinking water contaminants including the
parasites Cryptosporidium and Giardia. The US EPA is responsible for
assessing the parasite occurrence in raw surface waters used as source water
for drinking water treatment plants. EPA Method 1623 was designed as the
detection method for Cryptosporidium and Giardia in water from the treatment
plants. The results were submitted to the US EPA for the purpose of monitoring
the source water and to determine if additional treatment is required. This is
essential to monitor increases in microbial risk that may occur when systems
implement the Stage 2 Disinfectants and Disinfection Byproducts Rule (Stage 2
DBPR). Depending on the results of the tests facilities may have to install new or
additional treatment and filtration systems as well as submit additional samples
for testing. E. coli detection is enacted first as a cost saving method due to the
high costs of collection and analysis of water samples for Cryptosporidium and
Giardia. Price variance occurs between labs, but in general a total coliform
analysis costs less than $70 while EPA Method 1623 Cryptosporidium and
Giardia testing costs over $500. E. coli coliform testing detects the presence of
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fecal contamination in water. As Cryptosporidium and Giardia are passed into
water through contaminated feces monitoring first for the presence of fecal
contamination is a time and cost saving measure. In order to assure that steps
taken to minimize cyst and oocysts presence in the wastewater effluent are
successful facilities that have had a positive test result are required to submit
subsequent samples for testing in a sped-up timeframe until they have negative
results.
The different policies enacted monitor potable and surface water sources
primarily due to the use of reclaimed water. While the US EPA has established
guidelines for reclaimed water it does not regulate its use. Regulation is left to
each individual state and the state’s interpretation of the guidelines, leading to
varying definitions and uses. Reclaimed or “reuse” water is considered to be
wastewater (sewage) that is treated to remove certain solids and impurities. The
practices of “re-using” water were implemented to ensure freshwater
conservation and sustainability for the alleviation of water shortages (Levine and
Asano, 2004). The increasing municipal water demand in populated areas is
another reason wastewater reclamation is being enacted. Reclaimed water is
not treated to the same degree as potable water before use. Thorough treatment
methods are needed to ensure that there is no contamination by Cryptosporidium
and Giardia. Reclaimed water that is not properly treated may contain infectious
cysts and oocysts. Reclaimed water is used for fire suppression, dust control,
and irrigation of agricultural and recreational areas such as golf courses,
playgrounds, and public parks. Agricultural use of contaminated reclaimed water
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can lead to contaminated food. Recreational irrigation with contaminated
reclaimed water can lead to increased exposure to humans. According to one
statistic EPA released online: approximately 673 million gallons per day of
reclaimed water was reused for beneficial purposes in 2009 in Florida. This
highlights the importance of monitoring wastewater effluent in order to decrease
any possible transmission of protozoan parasites to humans.

Wastewater Treatment
Many different methods are utilized in the treatment of wastewater, but
almost all of them are 5-stage biological nutrient removal (BNR) processes. BNR
removes nitrogen and phosphorus from wastewater through the use of various
microorganic conditions (U.S. E.PA, 2007). The 5-stage BNR process has been
shown to remove more wastewater nutrients, such as nitrogen, phosphorus, and
oxygen, and thus provides better treatment of the water (Uygur, 2004). Often the
activated sludge method is used in treatment due to its role in the breakdown of
biomass (Fenu, et al, 2010) and its relative simplicity (Vigne, et al, 2010).
Through a series of aerobic, anaerobic, and anoxic tanks carbon, nitrogen,
phosphorus, metals, and pathogens are removed from the water (Song, et al,
2010; Bok, et al, 2002). Throughout each stage several biochemical reactions
take place in the treatment of various contaminants (Goel, et al, 1998). The
anaerobic stage is primarily responsible for pathogen removal (Novak, et al,
2010).
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Tertiary treatment, such as filtration and disinfection, are necessary for
removal of microorganisms from wastewater systems (Koivunen, 2003). Through
the entire process most of the microorganisms in the water are removed in the
filtration stage. To date no filtration method has been developed that is capable
of eliminating all of the cysts and oocysts; the best methods filter out 99% of
Cryptosporidium oocysts (U.S. E.P.A., 2001).
Continuous backwash filtration is a method of water filtration that employs
granular media filter beds. The basic principle is that effluent water flow is
reversed in a section of the filter bed media and pumped through the media in
the opposite direction of regular flow (England, 1994). This dislodges waste from
the media and mixes the media to a more optimal density allowing better water
flow and filtration. In most systems the backwash water is discarded due to the
high amount of waste in it. Backwash water is commonly discarded by
discharged into a sanitary sewer, transport to a sewer plant or landfill, or sent to
a basin where the solids are settled out. It is also mixed with the plant influent
and re-cycled through the plant. All of the methods for disposal of backwash
water are highly regulated due to the presence of contaminants. A continuous
backwash method keeps the filter media from getting clogged and also
eliminates the need to shut down for filter cleaning. It also eliminates the rush of
“dirty” water that happens when the flow is restored.
A method that is gaining popularity is continuous backwash, upflow, deep
bed, granular media (sand) filtration. This combines several proven effective
filtration methods into one system. Influent water is pumped into the central feed

15

chamber of the tank. From there it is injected into the bottom layer of granular
media and flows upward to the top of the tank. As the water travels upward the
waste is caught in the media. The water is cleaned during the entire travel
through the media because the sand is clean at the top of the tank. The heavy
waste-laden sand sinks to the bottom of the tank, as it sinks to a level below the
influent injection it is pumped vertically through an airlift where it is heavily
scoured and the waste is removed. Once the sand reaches the top of the airlift it
flows into a reject compartment where the lighter weight waste floats into the
reject pipe as the sand falls into the washbox. Due to the difference in water level
between the filtrate pool and the reject weir a small amount of polished water
flows upward creating a counter-current that carries the remaining waste back
into the reject weir while further cleaning the returning sand. The clean sand falls
out of the washbox and forms the top layer of the media bed. This process allows
for influent water to constantly flow through continuously cleaned sand while it is
filtered (England, Darby, and Tchobanoglous, 1994).
Shallow bed backwash systems in use have a media depth of one to two
feet and are generally traveling bridge systems. These systems can be
continuous backwash systems but are generally downflow as opposed to the
upflow system mentioned previously. While the upflow methods utilize narrow,
deep beds downflow methods utilize a wide, shallow horizontal media bed.
Systems that are not continuous backwash need to have cells routinely shut
down for a backwash when necessary. As this process can lead to large drops in
water pressure, can be extremely time consuming, and is not optimal for large
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systems, it has been losing popularity (England, Darby, and Tchobanoglous,
1994). Larger facilities with shallow bed filters can be continuous backwash
facilities when employing a traveling bridge filter. A traveling bridge filter does not
require periodic shut down and it does not use backwash water holding tanks.
The traveling bridge moves along the media bed and backwashes one section at
a time.
Deep bed multimedia filtration consists of granular media that is over four
feet deep. Most deep bed filters are downflow with layers of granules that are
consecutively smaller in diameter with each new layer. The media most
commonly used in various multimedia filters are sand, anthracite, garnet,
ilmenite, alumina, and magnetite (Sutherland, 2009). The number and amounts
of different media used varies with each facility. The cost of each media as well
as transportation and storage costs of high density media are factors for
determining the media used. Anthracite coal is widely used because it has a
unique density allowing it to stay above other filter mediums easily, it has high
carbon content, and its low uniformity allows for differing levels of solid waste
penetration resulting in high flow rate and prefiltration. Granulated garnet is used
because it has some of the same properties as anthracite and is a high density
media. Ilmenite is used to promote coagulation. Alumina is used primarily as a
flocculating agent and also reduces the amount of fluoride in the water.
Coagulation and flocculating agents are important as they cause organic
materials to agglomerate forming larger and heavier particles which are then
caught in the various filters. Magnetite is used as a sorbent for arsenic. As the
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water flows through the media it is cleaned and the polished effluent exits at the
bottom of the tank. Backwashing for these systems is an involved and time
consuming process as clean water is pumped backward through the filter to
dislodge waste. The waste is resuspended resulting in a highly contaminated
liquid that must be specially disposed of.
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Statement of the problem
The purpose of this study was to determine if county of collection,
watershed of collection, facility of collection, method of treatment, method of
filtration, and laboratory examining the sample were factors in the quality of
wastewater effluent through the presence of Cryptosporidium oocysts and
Giardia cysts in samples submitted for testing.
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Materials and Method
From 1998 to 2010 there were 234 facilities that submitted samples to 11
different laboratories for testing to detect Cryptosporidium oocysts and Giardia
cysts. The 863 samples selected were samples that had been analyzed for both
Cryptosporidium and Giardia. All of those samples were from effluent of
wastewater facilities and thus were from facilities that may pose a public health
risk if their effluent was contaminated. The records for the following information
were reportedly submitted and recorded when samples were submitted: facility
name, address, identification number, and permit number; facility water treatment
and water filtration methods; sample collection, submission, and analysis dates;
organization collecting the sample; organization analyzing the sample; and the
sample results. Due to discrepancies such as submitters filling out submission
inadequately, incorrectly and/or inconsistently not all of the information was
available. Information for the total daily volume and capacity for each facility at
the time of sample collection was not tracked and thus was not examined.
Linear multivariate regression analysis of the different variables was
unable to be done due to multiple gaps in information. The results obtained were
from different databases for sample information, facility information, and contact
information. The information for facility size and capacity was not enough for
significant data to be obtained. Because there was such a scarcity of information
for facility size and capacity in general, let alone the specific size and capacity of
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the facility at the time the sample was collected, no analysis of impact of the
facility size and capacity was able to be done. Unless otherwise stated the
program used to compile and compare the data was Microsoft Excel 2003. With
this program charts, pivot tables, percentages, sums, linear regression lines, and
correlation coefficients were done.
In order to properly compare the different factors involving quality of
wastewater effluent supplemental data for county of collection, watershed of
collection, county population, and rate and incidence of cryptosporidiosis and
Giardiasis per county were needed. The county for each facility was determined
using the facility address and the county boundaries as defined by the State of
Florida. The watershed of each sample was determined by comparing the facility
collection address with the boundaries of the 29 major watersheds of Florida as
defined by The Florida Water Resource Management Division and Environmental
Assessment and Restoration Division of the Florida Department of Environmental
Protection (FL DEP, 2011). Information for the population per county, rates of
disease, and counts of disease were obtained from the Florida Community
Health Assessment Resource Tool Set established by the Florida Department of
Health Office of Health Statistics and Assessment (FLCHARTS, 2011).
Starting in the 1990s the EPA evaluated methods for the detection,
monitoring, and analysis of Cryptosporidium. The first procedure adopted was
the Information Collection Rule (ICR) Protozoan Method for Detecting Giardia
Cysts and Cryptosporidium Oocysts in Water by a Fluorescent Antibody
Procedure in 1995 (U.S. E.P.A., 1995). Method 1622 was released as final in

21

1999, then updated in 2005 but it only included detection for Cryptosporidium
(U.S. E.P.A., 2005). In 1999 a revised method for simultaneous detection of
Cryptosporidium and Giardia, Method 1623, was validated and released (U.S.
E.P.A., 1999). Both Method 1622 and Method 1623 were revised in 2001 with
method updates including new filter and antibody stain components, clarified
sample acceptance criteria, modified sample testing procedures, updated quality
control acceptance criteria, and inclusion of spiking suspensions. To support the
Long Term 2 Enhanced Surface Water Treatment Rule revisions to both Method
1622 and Method 1623 were made in 2003 and 2005 (U.S. E.P.A. Method 1622,
2005) (U.S. E.P.A. Method 1623, 2005). The 2003 revisions included a modified
version of the methods using a new type of filter, approval oocysts and cysts for
quality control samples from a different manufacturer, new rejection criteria for
samples, guide for measuring sample temperatures, quality control sample
requirements and results clarification, guidance for staining slides, and other
minor corrections. For 2005 the revisions include approval of a continuous-flow
centrifugation method, addition of a new monoclonal antibody stain, and
clarification of analyst verification and sample condition criteria. The sample
collection, storage, and analysis procedures changed by varying degrees with
each revision. Due to these revisions sample quality that was acceptable in 2000,
may not have been unacceptable in 2007. Because of the various changes in
product vendors and method procedures the samples themselves would not
have been processed the same over the course of the revisions. In order to
reduce some of the bias effect this may have caused only samples that were
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simultaneously tested for Cryptosporidium and Giardia were analyzed. To
minimize possible detection bias only the overall results of positive (cysts or
oocysts detected) and negative (no cysts or oocysts detected) were used, overall
organism count and organism viability were not factored into the results.
Only sample results for samples that were simultaneously examined for
Cryptosporidium and Giardia were used in this study. The EPA ICR Protozoan
Method and the EPA Method 1623 are the rules that explicitly cover this type of
analysis and detection. In the earlier ICR Protozoan Method a large volume of
water is passed through a yarn-wound filter. Protozoa are eluted from the filter
and cysts and oocysts are separated from other particulate debris by flotation on
a Percoll-sucrose solution. The water layer/Percoll-sucrose interface is placed on
a membrane filter, stained, and then examined under a microscope. A major
drawback to this method is that it is a very time consuming process.
An advanced protozoan detection method, Method 1623, was created as
a performance based method, meaning that modifications of the method may be
used if they show equivalent or better performance. For this method a sample of
approximately 10 liters is pumped through an approved 1-micron membrane
filter. The filters are submitted to an approved lab for analysis. To retard any
degradation of cysts or oocysts captured on the filter samples are shipped on ice
and stored in a cooler prior to analysis. Within 96 hours of sample collection
filters are eluted with an aqueous buffered salt and detergent solution to wash
cysts and oocysts from the filter. The eluate is then concentrated and purified.
Magnetic beads that are conjugated to antibodies for Cryptosporidium and
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Giardia are added to the concentrate along with buffering agents and the mixture
is then rotated. After rotation a magnetic particle concentrator is used to separate
the magnetized cysts and oocysts from extraneous material. The resulting
bead/cyst bead/oocysts complexes are washed with acid to dissociate the cysts
and oocysts from the beads. The now purified sample is applied to a slide with a
small amount of base solution and allowed to dry. Within 72 hours of application
of purified sample to the slide the slide is stained with fluorescently labeled
monoclonal antibodies to Cryptosporidium and to Giardia and 4’,6-diamidino-2phenylindole (DAPI). The stained sample slide is then examined within 7 days by
an experienced laboratory technician using epifluorescence and differential
interference contrast (DIC) microscopy. The results of the slides are recorded
and reported.
The ICR Protozoan Method and Method 1623 have similar limitations:
neither method is able to identify the species of organism or the host species;
organic and inorganic debris can interfere with the sample analysis; organisms
and debris that fluoresce can interfere with cyst and oocysts microscopic
detection; freezing of the sample, filter, eluate, concentrate, or slides can
interfere with detection; and inappropriately maintained laboratory equipment can
affect detection. An advancement of the Method 1623 is that with the DAPI
staining it is possible to determine the viability of detected cysts and oocysts
whereas the ICR Protozoan Method cannot.
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Results and Discussion
Due to current state regulations positive tests necessitate multiple further
samples be submitted for testing. It follows that original effluent quality is a major
determinant in the number of samples submitted. To examine if this was in fact
true, a comparison of the number of positive samples to the overall number of
samples submitted for each county was done. The data was fit to a linear
regression line with a 0.78 coefficient of correlation. A considerable positive
correlation between the number of positive samples and the overall number of
samples submitted per county exists. Another comparison of the percent positive
samples to the overall number of sample submitted for each county was done.
This yielded a coefficient of correlation of 0.02 for this data set. This suggests
that the most significant relation between a county having positive samples is the
overall number of samples submitted, with the percent positive having little to no
significant relation.
Each sample submitted was simultaneously tested for Cryptosporidium
oocysts and Giardia cysts. Therefore each sample had two results but for the
purpose of analysis was only considered as a single sample. In order to more
accurately reflect this in the results the data for certain analysis was grouped
together. As seen in Table 1 of the 863 samples submitted Cryptosporidium
oocysts were detected in 52% and Giardia cysts were detected in 65% of the
samples. For 99% of the samples that had Giardia cysts detected,
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Cryptosporidium oocysts were also detected. For almost every county Giardia
cysts were detected in more wastewater effluent samples than Cryptosporidium
oocysts and the occurrence of Giardiasis was higher than that of
Cryptosporidiosis. This is easily explained by two facts 1) Giardiasis has long
been a disease with a much higher incidence and prevalence than
Cryptosporidiosis and 2) Cryptosporidium oocysts are harder to detect than
Giardia cysts.

Table 1. A comparison of the percent of samples testing positive for detection of
Cryptosporidium oocysts and/or Giardia cysts for all samples submitted for
Cryptosporidium and Giardia testing (1998 – 2010).
Comparison of the Percent Positive Samples for All Samples Submitted for
Cryptosporidium and Giardia Testing
(1998 – 2010)

Cryptosporidium
Giardia

Percent Positive
52%
65%

A comparative analysis of results to determine if a significant difference in
detection was noted with respect to sample collection and analysis method for
the ICR Protozoan Method and Method 1623 was attempted. Due to lack of
information for collection and analysis method for specific samples an exact
analysis of the difference in methods was not possible. However, in the first
years of sampling the prevalent method was the ICR Protozoan Method with
Method 1623 being the prominent method in recent years. Thus in an attempt to
analyze a possible difference in the efficacy of detection methods sampling data
from 1998 to 2001 was compared with sampling data from 2009 to 2010. In
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Table 2 this data, including the different percents positive, for samples submitted
for testing is presented. For the time periods the 2009 to 2010 period had an
overall percent positive of 73.0 % compared to that of 36.7 % for 1998 to 2001.
This difference suggests that the detection methods, the ICR Protozoan Method
and Method 1623, may play a role in the detection of oocysts and cysts in the
samples. This does not rule out the possibility that during that amount of time the
actual presence of oocysts and cysts increased. A list of the counties submitting
samples for the two time periods is available in Appendix E.
Table 2. A comparison of counties submitting samples for Cryptosporidium and
Giardia testing by number of counties submitting samples, total number of
sample submitted, overall percent positive for all counties, and the percent
positive of the 18 counties that submitted samples for 1998 to 2001 and for 2009
to 2010.
Data for All Samples Submitted for Cryptosporidium and Giardia Testing for
1998 to 2001 Compared to That of 2009 to 2010
1998 - 2001

2009 - 2010

Number of Counties
Submitting Samples

20

33

Total Number of Samples
Submitted for Testing

166

248

Overall Percent Positive of
All Counties

36.7 %

73.0 %

Percent Positive of the
Same 18 Counties

37.0 %

69.5 %

Of the 67 counties in Florida: 27 did not submit any samples; of the 40 counties
that did submit samples 15 counties submitted ten or less samples; and only
27

Hillsborough, Pinellas, Sarasota, and Volusia counties submitted over 50
samples. It is incredibly important to note the 40 counties that did not account for
any samples. In Florida there are currently over 3,700 individually permitted
wastewater facilities. Treatment facilities not under the influence of surface water,
that serve less than 10,000 people, and that are filtered are not necessarily
required to submit samples. The samples in this study were collected from 234
wastewater facilities. A limitation of this study is that it only had test results for
approximately 5% of the wastewater treatment facilities in Florida. Analysis of the
difference between the variables examined for the facilities that submitted
samples versus those that did not was unable to be done. It is possible that
significant information on the efficacy of treatment and filtration methods is
therefore undetected.
The number of facilities in any area depends on the water usage and
consumption for that area as well as the capacity of the facilities in that area. The
amount of wastewater produced is directly proportional to the water use in an
area. Because water usage is a function of the population of an area the rate of
samples submitted per 100,000 people per county could demonstrate if the
population of a county could be the most important determiner in the number of
samples submitted for that county. This accounts for the difference of population
density of the areas submitting samples. Figure 1 is a graph of the rate of
samples submitted for Cryptosporidium and Giardia testing per 100,000 people
per county (1998-2010). As previously described the population information was
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taken from Florida CHARTS. The data used was an average of the population in
each county per year for the years 1999 to 2010.
If the factors affecting the effluent quality of wastewater treatment facilities
were equivalent the rate of samples per 100,000 people per county would be
similar. Figure 1 demonstrates that there is a difference, but not does not
demonstrate the reason for the difference. This difference could be explained by
the number of facilities submitting samples and the size of facilities submitting
samples. In an effort to examine if there was an obvious geographic link to the
distribution of counties in which a higher rate of samples was submitted a map of
Florida counties with the associated rate was made, this is represented in Figure
2. There was no obvious link between the geographical location of a county and
the rate of samples that were submitted in that county per 100,000 people. Some
counties that have the larger populations are among the counties submitting the
lower numbers of samples, such as Monroe, Miami-Dade, Palm Beach, Duval,
Hillsborough, and Pinellas counties. A possible explanation for this is that
counties with larger populations have facilities that account for a greater
proportion of the population. It is also possible that counties with greater
populations have better means of maintaining their treatment facilities.
Comparing Figure 2 and Figure 3 shows that counties with higher rates of
samples submitted are not always the counties with the greater number of
facilities submitting samples. This leads to the conclusion that there may be a
difference between the sizes of the facilities or that certain counties with larger
populations are better able to maintain their treatment facilities.
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Figure 1. Rate of samples submitted for Cryptosporidium and Giardia testing per
100,000 people per county 1998-2010. The population used was an average
population for each county for 1998 through 2010.
A comparison of the rate of samples submitted for Cryptosporidium and
Giardia per 100,000 for each county versus the rate for each watershed was not
able to be done. There was no population information available for the watershed
to do a rate comparison with.
Figure 3 is a map of the number of facilities submitting samples for
Cryptosporidium and Giardia testing per county for 1998 through 2010. A
calculation for the rate of facilities submitting samples per 100,000 for each
county was unable to be done due to limitations of the data available. There was
no distinct pattern of the number of facilities that submitted samples per county
seen on the map in Figure 3.
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Figure 2. Map of Rate of samples submitted for Cryptosporidium and Giardia
testing per 100,000 people per county 1998-2010. The population used was an
average population for each county for 1998 through 2010.
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Figure 3. Map of the number of facilities submitting samples for Cryptosporidium
and Giardia testing per county for 1998 through 2010.
The map of the number of facilities submitting samples for
Cryptosporidium and Giardia testing per watershed for 1998 through 2010,
Figure 4, also shows no distinct pattern of distribution for the areas submitting a
greater number of samples. However, the map demonstrates that for the
southern tip of Florida a wide area of the Florida Everglades accounts for an area
where no samples were taken from. Much of this area is either rural, agricultural,
or protected land with no or few wastewater treatment plants and is therefore not
expected to be submitting samples for testing. When comparing this with Figure
3 it demonstrates the idea that for certain areas where there is a greater
population, such as coastal south Florida, there will be more facilities submitting
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samples. The corresponding watersheds for areas with high sample levels show
this distinct division between coastal areas and inland areas. A watershed is
defined as an area or region that is drained by a river, river system, or other body
of water. This means that watersheds right next to each other will have waters
that flow into different rivers, basins, or bodies of water. When a river or lake is
contaminated by wastewater effluent that has cysts and/or oocysts in it the entire
watershed it resides in is at an increased risk of becoming contaminated. If a
specific county had a greater number of samples submitted by a small number of
facilities it could be inferred that the facilities were then unable to appropriately
treat their water.
Of the 29 main watersheds in Florida three did not have any samples
submitted: Chipola River, Fisheating Creek, and Perdido River. Figure 5 is a map
of the distribution of the number of samples submitted for Cryptosporidium and
Giardia testing per watershed between 1998 and 2010.
When examining Figures 4 and 5 it is apparent that the watersheds where
there were a greater number of samples collected coincided with the areas
where there were a greater number of facilities that submitted samples for
Cryptosporidium and Giardia testing. This also demonstrates that in the
watersheds the areas where a greater number of samples were submitted did not
have a small number of facilities accounting for the samples.
Three different filtration methods, continuous backwash (18.8%), deep
bed multi media (20.7%), and shallow bed backwash (36.9%), accounted for
76.4% of the total samples. Of the remaining samples nine different filtration
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methods were used, due to the small number of facilities utilizing these methods
no further analyses was performed on those filtration methods.
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Figure 4. Map of the number of facilities submitting samples for Cryptosporidium
and Giardia testing by watershed for 1998 through 2010.
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Figure 5. Map of the distribution of the number of samples submitted for
Cryptosporidium and Giardia testing per watershed between 1998 and 2010.

Continuous backwash, deep bed multi media, and shallow bed backwash
filtration systems had similar positive percentage rates of detection for
Cryptosporidium and/or Giardia of 58.3%, 52.6%, and 59.8%, respectively. The
differences in the percentages where not large enough to be considered
statistically significant: p-values were all greater than 0.5, meaning the
hypothesis that they were not significantly different was correct.
When examining the distribution of the three main filtration methods by
county Figures 6A and 6B shows that all three filtration methods had some
overlapping areas of numbers of facilities submitting samples. The number of
facilities within each county that used continuous backwash filtration, deep-bed
multi media filtration, and shallow-bed automatic backwash were grouped to
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compare whether any area had a more prominent number of a specific filtration
method, this is shown in Figure 6A. In order to examine a geographic pattern of
the distribution of the three different filtration methods a map of the information in
Figure 6A was made, Figure 6B.
When comparing the percent positive and areas of location of different
filtration methods in place no discernable pattern emerged as to one filtration
method having better or worse detection limits or geographical association.

Number of Facilities per County Comparison of Filtration Method between Continuous
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Figure 6A. The number of facilities per county for the three different filtration
methods of continuous backwash, deep-bed multiple media, and shallow-bed
automatic backwash grouped together.
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Figure 6B. Distribution of the number of facilities per county for the three
different filtration methods of continuous backwash, deep-bed multiple media,
and shallow-bed automatic backwash grouped together.

A comparison was done for the four laboratories where the greatest
number of samples submitted for Cryptosporidium and Giardia testing were
analyzed. Figure 7 shows the overall number of samples that were negative,
number of samples that were positive, and the percent positive of samples for
those laboratories. The frequency of detection of cysts and oocysts could be a
function of the specific lab that did the analysis. Each facility did not submit
samples to the same laboratory for testing each time a sample was taken. This
eliminates some of the bias present for each facility specifically accounting for
positive samples. There were 11 laboratories that analyzed samples. Of those 11
only four laboratories had analyzed enough samples to be statistically
comparable. These labs will be referred to as Laboratory A (a county water
utility), B (a commercial laboratory), C (a state public health laboratory), and D (a
university laboratory). The percent positive of samples was not statistically
significant between Laboratory A and Laboratory C (p-value = 0.15). There was a
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significant difference in the percent positive of samples between Laboratory A
and Laboratory B (p-value < 0.0001), as well as Between Laboratory B and
Laboratory C (p-value < 0.0001). Laboratory D had a significant difference from
all of the others labs, but was statistically closer to the results from Laboratory C
than any other laboratory. Of these results the most intriguing is that of the
differences between Laboratories A, B, and C. Laboratory C analyzed a greater
quantity of samples but still had a similar percent positive to that of Laboratory A.
Laboratory B had a significantly smaller percent positive than all the other labs.
These results point towards a significant difference in the number of samples in
which oocysts and cysts are detected depending on the laboratory analyzing the
samples. Tying these results in with those shown in Table 2 a cause of the
significant difference in the percent positives of samples may be the laboratory
that does the testing as well as which method of detection that laboratory utilizes.
Results of Samples Submitted for Cryptosporidium and Giardia Testing per
Laboratory
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Figure 7. The overall number of samples that were negative, number of samples
that were positive, and the percent positive of samples for Laboratory A,
Laboratory B, Laboratory C, and Laboratory D.
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Because of the health risks posed by wastewater contaminated with
Cryptosporidium oocysts and Giardia cysts the rates of samples positive for each
county were compared with the rates of cryptosporidiosis and giardiasis for 1998
through 2010, see Figure 8 for rate of cryptosporidiosis and Figure 9 for
giardiasis. As described previously, the rates of cryptosporidiosis and giardiasis
for all Florida counties were obtained from Florida Charts. Madison County was
the only county that had no reported cases of cryptosporidiosis and has one of
the smallest levels of Giardiasis. A possible explanation for this is human to
human spread of disease as opposed to individual cases all being caused by
contact with contaminated water.

Average Rate of
Cryptosporidiosis per 100,000
People by County (1998-2010)
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5.50 – 5.99
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> 6.50

Figure 8. Map of the average rate of cryptosporidiosis per 100,000 people by
county during 1998 through 2010.
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Figure 9. Map of the average rate of giardiasis per 100,000 people by county
during 1998 through 2010.
The quality of effluent water from wastewater treatment facilities in Florida
varies by county and by watershed. When examining the rate of samples
submitted for a county and the rate of disease of that county there seems to be
an almost inverse proportion. This would seem to suggest that areas in which
there is a higher burden of disease may be in areas where it seems that the
facilities do not need to do sample testing or are areas in which there are no
large treatment facilities that are required to submit samples for testing. This
could also mean that areas with smaller treatment facilities that are not required
to submit samples under the current rule do, in fact, need to be doing sample
testing. It could also suggest that in areas that the quality of the effluent
wastewater is inadequate, as evidenced by detection of cysts and oocysts, the
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route of transmission for the disease is not necessarily from contaminated
wastewater effluent but possibly human to human contact. It is evident that
further monitoring of the differences between laboratories analyzing samples, as
well as the method of analysis, is needed.
Significant public health risks are still posed by Cryptosporidium and
Giardia, further monitoring and evaluation of source water treatment and filtration
methods is necessary to accurately address their levels in water supplies.

41

List of References

Adam, R. D. (2001). Biology of Giardia lamblia. Clinical Microbiology Reviews, 14
(3), 447-475. doi: 10.1128/CMR.14.3.447-475.2001

Akiyoshi, D.E., Dilo, J., Pearson, C., Chapaman, S., Tumwine, J., & Tzipori, S.
(2003). Characterization of Cryptosporidium meleagridis of human origin
passaged through different host species. Infection and Immunity, 71(4),
1828-1832, doi: 10.1128/IAI.71.4.1828-1832.2003

Baker, J.R. (2007). Advances in Parasitology. Elsevier Science & Technology
Books. p. 131.

Bok, P. J., Lee, H. W., Lee, S-Y., Lee, J.O., Bang, I.S., Choi, E. S., … Park, Y. K.
(2002). Microbial community analysis of 5-stage biological nutrient
removal process with step feed system. Journal of Microbiology and
Biotechnology, 12(6), 929-935

Cama, V.A., Ross, J.M., Crawford, S., Kawai, V., Chavez-Valdez, R., Vargas, D.,
… Xiao, L. (2007). Differences in clinical manifestations among
Cryptosporidium species and subtypes in HIV-infected persons. The
Journal of Infectious Diseases, 196, 684-91, doi: 10.1086/519842

Chakrabarti, R. & Chakrabarti, D. (2009). Chemotherapeutics of neglected
waterborne parasites: Current status and future perspectives. Molecular
and Cellular Pharmacology, 1(2), 98-102, doi:
10.4255/mcpharmacol.09.12

Chalmers, R. M., Sturdee, A. P., Bull, S. A., Miller, A., and S. E. Wright (1997)
The prevalence of Cryptosporidium parvum and C. muris in Mus
domesticus, Apodemus sylvaticus and Clethrionomys glareolus in an

42

agricultural system. Parasitology Research, 83 (5), 478-482, doi:
10.1007/s004360050283

Champliaud, D., Gobet, P., Naciri, M., Vagner, O., Lopez, J., Buisson, J.C.,
…Bonnin, A. (1998). Failure to differentiate Cryptosporidium parvum from
C. meleagridis based on PCR amplification of eight DNA sequences.
Applied and Environmental Microbiology, 64(4), 1454-1458

Cizek, A. R., Characklis, G. W., Krometis, L-A., Hayes, J. A., Simmons III, O. D.,
Di Lonardo, S., … Sobsey, M. D. (2008). Comparing the partitioning
behavior of Giardia and Cryptosporidium with that of indicator organisms
in stormwater runoff. Water Research, 42 (17) 4421-4438. doi:
10.1016/j.watres.2008.06.020

Current, W. L. & Garcia, L. S. (1991). Cryptosporidiosis. Clinical Microbiology
Reviews, 4 (3), 325-358. doi: 10.1128/CMR.4.3.325

Corsi, P.S., Kramer, M.H., Blair, K.A., Addiss, D.G., Davis, J.P., & Haddix, A. C.
(2003). Costs of illness in the 1993 waterborne Cryptosporidium outbreak,
Milwaukee, Wisconsin. Emerging Infectious Diseases, 9(4), 426-431, doi:
10.3201/eid0904.020417

Eisenstein, L., Bodager, D., & Ginzl, D. (2008). Outbreak of Giardiasis and
cryptosporidiosis associated with a neighborhood interactive water
fountain-Florida, 2006. Journal of Environmental Health, 71 (3), 18-22

England, S.K., Darby, J.L., & Tchobanoglous, G. (1994). Continuous-backwash
upflow filtration for primary effluent. Water Environment Research, 66(2),
145-152

Fayer, R., (2010). Taxonomy and species delimitation in Cryptosporidium.
Experimental Parasitology, 124, 90-97, doi:
10.1016/j.exppara.2009.03.005

Feng, Y., & Xiao, L. (2011). Zoonotic potential and molecular epidemiology of
Giardia species and Giardiasis. Clinical Microbiology, 24 (1), 110-140. doi
10.1128/CMR.00033-10

43

FL CHARTS (2011) Rates and counts for Cryptosporidosis and Giardiasis.
Retrieved from Florida Community Health Assessment Resource Tool Set
http://www.floridacharts.com/charts/Domain2.aspx?Domain='01'

FL D. E. P. (2011) Major watersheds of Florida. Retrieved from
http://www.protectingourwater.org/watersheds/map/

Fenu, A., Guglielmi, G., Jimenez, J., Sperandio, M., Saroj, D., Lesjean, B., …
Nopens, I. (2010). Activated sludge model (ASM) based on modeling of
membrane bioreactor (MBR) processes: A critical review with special
regard to MBR specificities. Water Research, 44, 4272-4294, doi:
10.1016/j.watres.2010.06.007

Furness, B. W., Beach, M. J., & Roberts, J. M. (2000). Giardiasis surveillance—
United States, 1992-1997. MMWR CDC Surveillance Summary, 49 (7), 113

Gardner, T.B., & Hill, D. R. (2001). Treatment of Giardiasis. Clinical Microbiology
Reviews, 14(1), 114-128, doi: 10.1128/CMR.14.1.114-128.2001

Goel, R., Mino, T., Satoh, H., & Matsuo, T. (1998). Enzyme activities under
anaerobic and aerobic conditions in activated sludge sequencing batch
reactor. Water Research, 32(7), 2081-2088, doi: 10.1016/S00431354(97)00425-9

Guerrant, R. L., Van Gilder, T., Steiner, T. S., Thielman, N. M., Slutsker, L.,
Tauxe, R. V., … Pickering, L. K. (2001). Practice guidelines for the
management of infectious diarrhea. Clinical Infectious Diseases, 32 (3),
331-351. doi: 10.1086/318514

Hunter, P. R., & Thompson, R. C. A. (2005). The zoonotic transmission of
Giardia and Cryptosporidium. International Journal for Parasitology, 35
(11-12), 1181-1190. doi: 10.1016/j.ijpara.2005.07.009

Interim Enhanced Surface Water Treatment Rule, 63 Fed. Reg 69477 (1998)

44

Kim, L. S., Stansell, J., Cello, J. P., & Koch, J. (1998). Discrepancy between sexand water-associated risk behaviors for Cryptosporidiosis among HIVinfected patients in San Fransisco. Journal of Acquired Immune Deficiency
Syndromes & Human Retrovirology, 19 (1), 44-49

Jex, A. R., Smith, H. V., Monis, P. T., Campbell, B. E., & Gasser, R. B. (2008).
Cryptosporidium – Biotechnological advances in the dectection, diagnosis
and analysis of genetic variation. Biotechnology Advances, 24 (4), 304317. doi: 10.1016/j.biotechadv.2008.02.003

Koivunen, J., Siitonen, A., & Heinonen-Tanski, H. (2003). Elimination of enteric
bacteria in biological-chemical wastewater treatment and tertiary filtration
units. Water Research, 37(3), 690-698, doi: 10.1016/S00431354(02)00305-6

Kosek, M., Alcantara, C., Lima, A.A.M., & Guerrant, R. L. (2001).
Cryptosporidiosis: an update. The Lancet Infectious Diseases, 1, 262-269

LeChevallier, M. W., Norton, W. D., & Lee, R. G. (1991). Giardia and
Cryptosporidium spp. in filtered drinking water supplies. Applied
Environmental Microbiology, 5(9), 2617-2621

Levine, A. D., & Asano, T.. (2004). Recovering sustainable water from
wastewater. .Environmental Science and Technology, 45, 203A.
doi:10.1021/es040504n

Long Term 1 Enhanced Surface Water Treatment Rule, Final Rule, 67 Fed. Reg.
1812. (2002)

Long Term 2 Enhanced Surface Water Treatment Rule, Final Rule, 71 Fed. Reg.
654. (2006)

Mercado, R., Buck, G. A., Manque, P. A., & Ozaki, L. S. (2007). Cryptosporidium
hominis infection of the human respiratory tract. Journal of Emerging
Infectious Diseases, 13 (3). doi: 10.3201/eid1303.060394

45

Mor, S.M., Tumwine, J.K., Ndeezi, G., Srinivasan, M.G., Kaddu-Mulindwa, D.H.,
Tzipori, S., … Griffiths, J. K. (2010). Respiratory Cryptosporidiosis in HIVseronegative children in Uganda: Potential for respiratory transmission.
Clinical Infectious Diseases, 50(10), 1366-1372, doi: 10.1086/652140

Nime, F. A., Burek, J. D., Page, D. L., Holscher, M. A., & Yardly, J. H. (1976).
Acute enterocolitis in a human being infected with the protozoan
Cryptosporidium. Gastroenterology 1976, (70), 592–8

Novak, J.T., Banjade, S. & Murthy, S. N. (2010). Combined anaerobic and
aerobic digestion for increased solids reduction and nitrogen removal,
Water Research, 45(2), 618-24, doi: 10.1016/j.watres.2010.08.014

Pieniazek, N.J., Bornay-llinares, F.J., Slemenda, S.B., da Silva, A.J., Moura,
I.N.S., Arrowood, M.J., … Addiss, D. G. (1999). New Cryptosporidium
genotypes in HIV-infected persons. Emerging Infectious Diseases, 5(3),
444-449

Pozio, E., Rezza, G., Boschini, A., Pezzotti, P., Tamburrini, A., Rossi, P., ...
Ballarini, P. (1997). Clinical cryptosporidiosis and Human
Immunodeficiency Virus (HIV)-induced immunosuppression: findings from
a longitudinal study of HIV-positive and HIV-negative former injection drug
users. The Journal of Infectious Diseases, 176, 969-75

Priest, J.W., Bern, C., Xiao, L., Roberts, J.M., Kwon, J.P., Lescano, A.G., …
Lammie, P. J. (2006). Longitudinal analysis of Cryptosporidium speciesspecific Immunoglobulin G antibody responses in Peruvian children.
Clinical and Vaccine Immunology, 13(1), 123-131, doi:
10.1128/CVI.13.1.123-131.2006

Rotz, L. D., Khan, A. S., Lillibridge, S. R., Ostroff, S. M., & Hughes, J. M. (2002).
Public health assessment of potential biological terrorism agents.
Emerging Infectious Diseases, 8 (2), 225-230. doi:
10.3201/eid0802.010164

Ruecker, N.J., Braithwaite, S.L., Topp, E., Edge, T., Lapenl, D.R., Wilkes, G., …
Neumann, N. F. (2007). Tracking host sources of Cryptosporidium spp. in
raw water for improved health risk assessment. Applied and

46

Environmental Microbiology, 73(12), 3945-3957, doi: 10.1128/AEM.0278806

Safe Drinking Water Act of 1974, Pub. L. 93-523, § 88 Stat. 1660 (1974)

Safe Drinking Water Act Amendments of 1986, Pub. L. 99-359, § 100 Stat. 642
(1986)

Song, L.J., Zhu, N.W., Yuan, H.P., Hong, Y., & Ding, J. (2010). Enhancement of
wastes activated sludge aerobic digestion by electrochemical pretreatment. Water Research, 44(15), 4371-8, doi:
10.1016/j.watres.2010.05.052

Stein, P. L. (2000). The great Sydney water crisis of 1998. Water, Air, and Soil
Pollution, 123, 419-436.

Sutherland, K. (2009). Filtration overview: A closer look at depth filtration.
Filtration+Separation.com retrieved from:
http://www.filtsep.com/view/841/filtration-overview-a-closer-look-at-depthfiltration-/ March 6, 2011

U.S. E.P.A. (1995) ICR Protozoan Method for Detecting Giardia Cysts and
Cryptosporidium oocysts in Water by a Fluorescent Antibody Procedure.
EPA/814-B-95-003. Retrieved from
http://www.epa.gov/nerlcwww/documents/pvid.pdf

U.S. E.P.A. (1999). Method 1623: Cryptosporidium and Giardia in Water by
Filtration/IMS/FA. EPA 821-R-99-006

U.S. E.P.A. (2001). Cryptosporidium: Human health criteria document. United
States Environmental Protection Agency, Office of Water, Office of
Science and Technology, EPA 822-K-94-001
U.S. E.P.A. (2005). Method 1622: Cryptosporidium in Water by Filtration/IMS/FA.
EPA 815-R-05-001. Retrieved from
http://www.epa.gov/nerlcwww/documents/1622de05.pdf

47

U.S. E.P.A. (2005). Method 1623: Cryptosporidium and Giardia in Water by
Filtration/IMS/FA. EPA 815-R-05-002. Retrieved from
http://www.epa.gov/nerlcwww/documents/1623de05.pdf

Uygur, A., & Kargi, F. (2004). Biological nutrient removal from pre-treated landfill
leachate in a sequencing batch reactor. Journal of Environmental
Management, 71(1), 9-14, doi: 10.1016/j.jenvman.2004.01.002

Vigne, E., Choubert, J-M., Canler, J-P., Heduit, A., Sorensen, K., & Lessard, P.
(2010). A biofiltration model for tertiary nitrification of municipal
wastewaters. Water Resources, 44, 4399-4410, doi:
10.1016/j.watres.2010.06.005

Xiao, L., Bern, C., Limor, J., Sulaiman, I., Roberts, J., Checkley, W., … Lal, A. A.
(2001). Identification of 5 types of Cryptosporidium parasites in children in
Lima, Peru. The Journal of Infectious Diseases, 183, 492-7

Zhou, L., Fayer, R., Trout, J.M., Ryan, U.M., Schaefer III, F.W., & Xiao, L. (2004).
Genotypes of Cryptosporidium species infecting fur-bearing mammals
differ from those of species infecting humans. Applied and Environmental
Microbiology, 70(12), 7574-7577, doi: 10.1128/AEM.70.12.75747577.2004

48

Appendices

Appendix A. List of Florida Counties
Alachua
Baker
Bay
Bradford
Brevard
Broward
Calhoun
Charlotte
Citrus
Clay
Collier
Columbia
DeSoto
Dixie
Duval
Escambia
Flagler
Franklin
Gadsden
Gilchrist
Glades
Gulf
Hamilton
Hardee
Hendry
Hernando
Highlands
Hillsborough
Holmes
Indian River
Jackson
Jefferson
Lafayette
Lake

Lee
Leon
Levy
Liberty
Madison
Manatee
Marion
Martin
Miami-Dade
Monroe
Nassau
Okaloosa
Okeechobee
Orange
Osceola
Palm Beach
Pasco
Pinellas
Polk
Putnam
Saint Johns
Saint Lucie
Santa Rosa
Sarasota
Seminole
Sumter
Suwannee
Taylor
Union
Volusia
Wakulla
Walton
Washington
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Appendix B. Map of Florida Counties

Figure A1. Map of Florida Counties

50

Appendix C. List of Florida Watersheds

Apalachicola – Chipola
Caloosahatchee
Charlotte Harbor
Choctawhatchee – St. Andrew
Everglades
Everglades West Coast
Fisheating Creek
Florida Keys
Indian River Lagoon
Kissimmee River
Lake Okeechobee
Lake Worth Lagoon – Palm Beach Coast
Lower St. Johns Nassau – St. Marys
Middle St. Johns
Ocklawaha
Ochlockonee – St. Marks
Pensacola
Perdido
St. Lucie – Loxahatchee
Sarasota Bay – Peace - Myakka
Springs Coast
Southeast Coast – Biscayne Bay
Suwannee
Tampa Bay
Tampa Bay Tributaries
Upper East Coast
Upper St. Johns
Withlacoochee
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Appendix D. Map of Florida Watersheds

Figure A2. Map of Florida Watersheds
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Appendix E. Lists of Counties Submitting Samples for Cryptosporidium
and Giardia Testing for 1998 to 2001 and 2009 to 2010

1998 to 2001
Bay
Brevard
Charlotte
DeSoto
Duval
Hillsborough
Lee
Manatee
Martin
Okaloosa
Osceola
Palm Beach
Pasco
Pinellas
Polk
Santa Rosa
Sarasota
Seminole
Sumter
Volusia

2009 to 2010
Alachua
Bay
Brevard
Broward
Charlotte
Collier
DeSoto
Duval
Hernando
Hillsborough
Indian River
Lake
Lee
Manatee
Marion
Martin
Miami-Dade
Nassau
Orange
Osceola
Palm Beach
Pasco
Pinellas
Putnam
Saint Johns
Saint Lucie
Santa Rosa
Sarasota
Seminole
Sumter
Volusia
Wakulla
Walton
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